after the cancer has metastasized. (10) Early-staged prostate cancer has no symptoms, raising the importance of early detection and screening. (11) The Department of Health and Human Services, the Department of Defense, and the Department of Veterans Affairs all have a role in providing care for and conducting research on prostate cancer. (12) Multiple institutes at the National Institutes of Health are engaged in prostate cancer care and research, including the National Cancer Institute, National Institute of Biomedical Imaging and Bioengineering, the National Institute on Minority Health and Health Disparities, and the Clinical Center. (13) Additional agencies and offices within the Department of Health and Human Services conduct activities related to prostate cancer, including the Centers for Medicare and Medicaid Services, the Centers for Disease Control and Prevention, the Food and Drug Administration, the Health Resources and Services Administration, the Office of Minority Health, and the Agency for Healthcare Research and Quality. (14) The Department of Defense created the Prostate Cancer Research Program in 1997 and has funded more than $2,000,000,000 in prostate cancer research since that time. (15) Private foundations have provided substantial funding to the prostate cancer research community for almost three decades, including support for over 200 cancer centers and universities. (16) The Director of the National Institutes of Health has partnered with private prostate cancer research groups to study to study biological and nonbiological factors associated with aggressive prostate cancer in African-American men. (17) The Secretary of Veterans Affairs has partnered with private foundations to establish precision oncology program hubs for prostate cancer. (18) The Director of the Centers for Disease Control and Prevention has partnered with multiple private stakeholder groups to increase awareness and education around prostate cancer in the general population and among high-risk groups. (19) Increased